GSK

Glaxo's Influenza Vaccine Gets FDA Nod for Label Expansion
Yahoo/Zacks.com
Mon, 01/15/18 - 09:40 am
GSK
flu vaccines
FDA
FluarixQuadrivalent
Closing JPM18: Winners and losers, brighter days for neuroscience
Biopharma Dive
Sat, 01/13/18 - 10:58 pm
JPMHC 2018
Neurosciences
China
Sanofi
tax reform
GSK
Biogen
Celgene
channel stuffing
GSK seeks to protect Advair through GBP1.2bn acquisition of Vectura
GoinPharma
Sat, 01/13/18 - 01:59 pm
GSK
Advair
Vectura
M&A
JPM18: GSK's Walmsley weighs in on Pfizer, gender diversity
Biopharma Dive
Wed, 01/10/18 - 06:53 pm
GSK
Emma Walmsley
Pfizer
Pharma CEOs
gender diversity
JPMHC 2018
GSK’s long-quiet cancer R&D group is ready to make some noise as it mounts a breakout late-stage effort
Endpoints
Wed, 01/10/18 - 10:15 am
GSK
R&D
cancer
GSK2857916
BCMA
FDA Pulls Boxed Warnings on Asthma Risks on Some Inhalers
RAPS.org
Thu, 12/21/17 - 10:35 pm
FDA
warnings
asthma
inhalers
ICS/LABA inhalers
GSK
Advair Diskus
AstraZeneca
Symbicort
Merck
Dulera
GlaxoSmithKline, now vying with AstraZeneca, scores brand-new market for Nucala
Fierce Pharma
Wed, 12/13/17 - 11:07 am
GSK
AstraZeneca
Nucala
eosinophilic granulomatosis with polyangiitis
Can GSK’s new R&D strategy resuscitate the worst performer in Big Pharma?
Endpoints
Mon, 12/11/17 - 09:55 am
GSK
R&D
Luke Miels
Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo
Fierce Pharma
Tue, 11/28/17 - 09:05 pm
GSK
cabotegravir
HIV
Endurant
ViiV
JNJ
Janssen
Novartis looks to poach Advair patients with positive Ultibro switching data
Fierce Pharma
Mon, 11/27/17 - 10:42 am
Novartis
Advair
Ultibro Breezhaler
GSK
COPD
GSK, Innoviva seek expanded label for triple inhaler
Drug Delivery Business News
Mon, 11/27/17 - 09:12 am
GSK
Innoviva
triple inhaler
Trelegy Ellipta
COPD
J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space
Yahoo/Zacks.com
Sat, 11/25/17 - 12:39 pm
JNJ
GSK
Jucala
HIV
GSK, Innoviva seek to expand scope of Trelegy Ellipta
Pharma Times
Fri, 11/24/17 - 09:34 am
GSK
Innoviva
Trelegy Ellipta
COPD
With billions riding on their success, GSK bags quick OK for its two-drug HIV combo Juluca
Endpoints
Tue, 11/21/17 - 10:47 pm
GSK
HIV
Juluca
ViiV
GlaxoSmithKline's Nucala, buoyed by its medical organization, ready to 'fiercely compete' with AstraZeneca
Fierce Pharma
Mon, 11/20/17 - 11:12 am
GSK
Nucala
AstraZeneca
Fasenra
eosinophilic asthma
asthma
Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid U.S. outbreaks
Fierce Pharma
Wed, 11/15/17 - 08:46 am
Merck
GSK
vaccines
drug shortages
hepatitis A
Vaqta
Havrix
GSK nabs Calico scientist Barron as new R&D head, Vallance quits
Yahoo/Reuters
Wed, 11/8/17 - 09:22 am
GSK
R&D
Calico Life Sciences
Witty to head up new U.K. speedy drug/device review system
Fierce Biotech
Sat, 11/4/17 - 08:45 am
Andrew Witty
UK
Accelerated Access Review
drug reviews
GSK
GlaxoSmithKline's Anoro tops Boehringer's Stiolto in head-to-head COPD tilt
Fierce Pharma
Sat, 11/4/17 - 08:44 am
GSK
Anoro Ellipta
Boehringer Ingelheim
Stiolto Respimat
COPD
GSK and Gilead go head to head as HIV drugs enter new phase
Reuters
Fri, 11/3/17 - 11:01 am
GSK
Gilead Sciences
HIV
Dolutegravir
bictegravir

Pages